Inhalation Sciences ships first fully commercialized DissolvIt[®][ ]module
In a historic move ISAB has shipped its first fully commercialized DissolvIt in vitro module. The original Purchase Order for the shipment, made in September 2018, was worth 65.000 euros. The shipment is to the central Swiss labs of a global ISAB customer. DissolvIt has delivered landmark Contract Research data for clients throughout its development and is in high demand for its unique IVIVC capabilities.DissolvIt has long been in demand—and now it’s being delivered. The fully commercialized iteration is being shipped to a client’s labs in Switzerland, following ten years of development